A Broward County judge has handed CVS, Walgreens and Walmart a courtroom victory that Florida hospital leaders had hoped to avoid, ruling against 16 facilities that claimed the pharmacy giants helped fuel the state’s opioid crisis. The loss shuts down, at least for now, one of the hospitals’ biggest bids to claw back hundreds of millions of dollars in treatment costs.
The suit, filed in 2019 as Florida Health Sciences Center, North Broward Hospital District v. CVS, Walmart and Walgreens, pulled in a roster of heavy-hitter institutions, including Broward Health, Tampa General Hospital and Good Samaritan Medical Center. Together they alleged roughly $528.3 million in direct opioid-related expenses, plus about $1.5 billion in follow-on care, according to Reuters. Chief Judge Carol-Lisa Phillips sided with the pharmacy chains, finding the hospitals’ racketeering theory was not backed by sufficient evidence.
The case went to trial in September 2025 and dragged on long enough to end in a mistrial after jurors could not agree on a verdict, court coverage shows. During that first go-round, hospital lawyers put internal sales figures and dispensing records under the jurors’ noses to argue the retailers helped saturate Florida communities with opioids. Defense teams countered that the pharmacies followed the law and did not conspire with manufacturers, according to Courtroom View Network.
After the latest ruling, CVS said it was pleased the judge rejected what it has long called a “meritless” lawsuit, while Walmart said the decision backs up its position that it did not cause injuries to Florida hospitals, according to Reuters. Walgreens’ legal team has similarly argued that the chains merely filled valid prescriptions and did not take part in any scheme with drugmakers to pump up sales.
All of this plays out against a national backdrop where opioid litigation and settlement talks continue to grind on. Across the country, the value of opioid-related settlements has climbed to about $57 billion, according to the Opioid Settlement Tracker, a reminder that while some courtroom doors are closing, other routes to compensation and remediation remain wide open.
What This Means For Other Cases
Judges have been all over the map on whether racketeering and public-nuisance theories can stick against pharmacy chains, and this decision drops another data point in a growing patchwork that tends to favor retailers. Courts elsewhere have taken different paths. In Ohio, for example, appellate judges tossed a $650 million judgment against the same trio of pharmacy chains, a precedent defense lawyers regularly point to, according to Bloomberg Law.
Next Steps
The hospitals are not completely out of moves. They can ask an appellate court to review Chief Judge Phillips’ ruling, push for a retrial on other claims, or test the settlement waters. After last year’s mistrial, the hospitals’ lawyers signaled they would seek another trial date, though it was not immediately clear whether they will now pivot to an appeal, according to Law.com.
For Florida hospitals, and for families still facing the fallout of the opioid epidemic, this ruling narrows one legal path to compensation even as the broader landscape of settlements and policy reforms continues to shift. Other plaintiff groups around the country will be watching closely as they decide whether to pin their hopes on courtroom showdowns or strike deals outside of trial.
